In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Axovan Ltd. completes $18.3mm in second round

Executive Summary

Through a second round private placement, Axovan Ltd. completed (Euro20.5mm), $18.3mm in equity financing. The lead investor for the placement was Atlas Venture. New investors included Heidelberg Innovation, NeoMed, Banque Cantonale Vaudoise Private Equity and all existing investors in the company.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register